Published in Blood on September 15, 1993
Clinical, hematological and genetic data of a cohort of children with hemoglobin SD. Rev Bras Hematol Hemoter (2016) 0.89
A fast response mechanism for insulin storage in crystals may involve kink generation by association of 2D clusters. Proc Natl Acad Sci U S A (2006) 0.79
Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science (1997) 4.25
Correction of sickle cell disease in transgenic mouse models by gene therapy. Science (2001) 3.25
A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med (1993) 2.76
Expression of an Arabidopsis potassium channel gene in guard cells. Plant Physiol (1995) 1.98
Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia. Nat Genet (1998) 1.98
Potassium uptake supporting plant growth in the absence of AKT1 channel activity: Inhibition by ammonium and stimulation by sodium. J Gen Physiol (1999) 1.90
Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. N Engl J Med (1985) 1.90
Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients. Proc Natl Acad Sci U S A (1985) 1.85
Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications. Proc Natl Acad Sci U S A (1989) 1.79
Geographic variability in access to primary kidney transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.77
Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol (2000) 1.63
Heterogeneity of red cells in the sickler: a characteristic with practical clinical and pathophysiological implications. Blood Cells (1982) 1.49
Erythrocytes in sickle cell anemia are heterogeneous in their rheological and hemodynamic characteristics. J Clin Invest (1983) 1.48
Nuclear magnetic relaxation dispersion in protein solutions. IV. Proton relaxation at the active site of carbonic anhydrase. J Biol Chem (1970) 1.32
The hematologic characteristics of sickle cell anemia bearing the Bantu haplotype: the relationship between G gamma and HbF level. Blood (1987) 1.29
An objective sign in painful crisis in sickle cell anemia: the concomitant reduction of high density red cells. Blood (1984) 1.27
Water exchange between red cells and plasma. Measurement by nuclear magnetic relaxation. Biophys J (1975) 1.25
Functions of AKT1 and AKT2 potassium channels determined by studies of single and double mutants of Arabidopsis. Plant Physiol (2001) 1.20
SC erythrocytes have an abnormally high intracellular hemoglobin concentration. Pathophysiological consequences. J Clin Invest (1982) 1.18
Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism. Blood (1998) 1.18
In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J Clin Invest (1995) 1.15
Water exchange across red cell membranes: II. Measurements by nuclear magnetic resonance T1, T2, and T12 hybrid relaxation. The effects of osmolarity, cell volume, and medium. J Membr Biol (1978) 1.14
Effect of magnetic susceptibility on nuclear magnetic resonance signals arising from red cells: a warning. Biochemistry (1983) 1.14
The role of the subependymal plate in glial tumorigenesis. Acta Neuropathol (1977) 1.12
Volume-stimulated, Cl(-)-dependent K+ efflux is highly expressed in young human red cells containing normal hemoglobin or HbS. J Membr Biol (1987) 1.10
Fetal expression of a human Agamma globin transgene rescues globin chain imbalance but not hemolysis in EKLF null mouse embryos. Blood (2000) 1.09
On the mechanism for the red-cell accumulation of mefloquine, an antimalarial drug. Biochim Biophys Acta (1984) 1.09
Vaso-occlusion by sickle cells: evidence for selective trapping of dense red cells. Blood (1986) 1.09
Deoxygenation inhibits the volume-stimulated, Cl(-)-dependent K+ efflux in SS and young AA cells: a cytosolic Mg2+ modulation. Blood (1987) 1.07
Hypoxia-induced in vivo sickling of transgenic mouse red cells. J Clin Invest (1991) 1.07
The pathophysiology of vascular obstruction in the sickle syndromes. Blood Rev (1996) 1.06
Transgenic mice expressing human sickle hemoglobin are partially resistant to rodent malaria. Blood (1993) 1.04
Reengineering the specificity of a serine active-site enzyme. Two active-site mutations convert a hydrolase to a transferase. J Biol Chem (1994) 1.04
Renal nitric oxide synthases in transgenic sickle cell mice. Kidney Int (1996) 1.04
HbS-oman heterozygote: a new dominant sickle syndrome. Blood (1998) 1.03
The effect of deoxygenation on red cell density: significance for the pathophysiology of sickle cell anemia. Blood (1982) 1.03
Electrospray mass spectrometry in the clinical diagnosis of variant hemoglobins. J Chromatogr (1991) 1.03
The Senegal DNA haplotype is associated with the amelioration of anemia in African-American sickle cell anemia patients. Blood (1991) 1.02
Site-specific spin trapping of tyrosine radicals in the oxidation of metmyoglobin by hydrogen peroxide. Biochem J (1998) 1.02
Some aspects of the pathophysiology of homozygous Hb CC erythrocytes. J Clin Invest (1981) 1.02
Two major forms of DNA (cytosine-5) methyltransferase in human somatic tissues. Proc Natl Acad Sci U S A (1999) 1.02
Generalized schemes for high-throughput manipulation of the Desulfovibrio vulgaris genome. Appl Environ Microbiol (2011) 1.02
Acute priapism associated with the use of sildenafil in a patient with sickle cell trait. Blood (2000) 1.01
The percentage of dense red cells does not predict incidence of sickle cell painful crisis. Blood (1986) 1.01
Characterization of glycated hemoglobin in diabetic patients: usefulness of electrospray mass spectrometry in monitoring the extent and distribution of glycation. J Chromatogr B Biomed Sci Appl (2001) 1.00
Characterization of adult alpha- and beta-globin genes in the zebrafish. Blood (1997) 0.99
Erythrocytic and vascular factors influencing the microcirculatory behavior of blood in sickle cell anemia. Ann N Y Acad Sci (1989) 0.99
Utilization of an active serine 101----cysteine mutant to demonstrate the proximity of the catalytic serine 101 and histidine 237 residues in thioesterase II. J Biol Chem (1992) 0.99
The unique red cell heterogeneity of SC disease: crystal formation, dense reticulocytes, and unusual morphology. Blood (1991) 0.96
Impairment of the growth of Plasmodium falciparum in HbEE erythrocytes. J Clin Invest (1981) 0.95
Ligand state of intraerythrocytic circulating HbC crystals in homozygote CC patients. Blood (1985) 0.95
Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys. Kidney Int (1998) 0.95
F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study. Blood (1993) 0.94
Reduced amelogenin-MMP20 interactions in amelogenesis imperfecta. J Dent Res (2008) 0.94
High levels of human gamma-globin gene expression in adult mice carrying a transgene of deletion-type hereditary persistence of fetal hemoglobin. Mol Cell Biol (1997) 0.92
Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse. Clin Cancer Res (1999) 0.92
Defining of the minimal domain of protein 4.1 involved in spectrin-actin binding. J Biol Chem (1995) 0.92
Dense cells in sickle cell anemia: the effects of gene interaction. Blood (1984) 0.91
The panoply of animal models for sickle cell anaemia. Br J Haematol (2001) 0.91
Senegal haplotype is associated with higher HbF than Benin and Cameroon haplotypes in African children with sickle cell anemia. Am J Hematol (1993) 0.91
Incorporation of norleucine at methionine positions in recombinant human macrophage colony stimulating factor (M-CSF, 4-153) expressed in Escherichia coli: structural analysis. Biochemistry (1994) 0.91
Velocity measurements of normal and sickle red blood cells in the rat retinal and choroidal vasculatures. Microvasc Res (2000) 0.90
Paradoxical increase of painful crises in sickle cell patients with alpha-thalassemia. Blood (1995) 0.89
Pulmonary entrapment of sickle cells: the role of regional alveolar hypoxia. J Appl Physiol (1985) (1996) 0.89
Collisionally activated dissociation and tandem mass spectrometry of intact hemoglobin beta-chain variant proteins with electrospray ionization. Biol Mass Spectrom (1993) 0.88
Carboxymethylation of the human estrogen receptor ligand-binding domain-estradiol complex: HPLC/ESMS peptide mapping shows that cysteine 447 does not react with iodoacetic acid. Steroids (1996) 0.88
Universal newborn screening for Hb H disease in California. Genet Test (2001) 0.88
Hb H hydrops foetalis syndrome: a case report and review of literature. Br J Haematol (2001) 0.88
Red cell distribution width parallels dense red cell disappearance during painful crises in sickle cell anemia. J Lab Clin Med (1985) 0.87
Retinal and choroidal neovascularization in a transgenic mouse model of sickle cell disease. Am J Pathol (1994) 0.87
Tandem mass spectrometry in the clinical analysis of variant hemoglobins. Rapid Commun Mass Spectrom (1990) 0.86
Are wider surgical margins needed for early oral tongue cancer? J Laryngol Otol (2012) 0.86
'Best clinical practice': assessment of processes of care and of outcomes in the US Military Health Services System. J Eval Clin Pract (1998) 0.86
A rat model for sickle cell-mediated vaso-occlusion in retina. Microvasc Res (1996) 0.85
Sickle cell painful crises: a multifactorial event. Prog Clin Biol Res (1987) 0.84
Inhibition of TNF-alpha-induced sickle RBC retention in retina by a VLA-4 antagonist. Invest Ophthalmol Vis Sci (2001) 0.84
Two distinct pathways mediate the formation of intermediate density cells and hyperdense cells from normal density sickle red blood cells. Blood (1998) 0.84
Rate of activation and deactivation of K:Cl cotransport by changes in cell volume in hemoglobin SS, CC and AA red cells. J Membr Biol (1994) 0.83
Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia. Blood Cells Mol Dis (1999) 0.83
Conformational changes in oxyhemoglobin C (Glu beta 6-->Lys) detected by spectroscopic probing. J Biol Chem (1996) 0.82
Laboratory diagnosis of hemoglobinopathies. Clin Biochem (1991) 0.82
The inhibition of hemoglobin C crystallization by hemoglobin F. J Biol Chem (1988) 0.82
Comparison of serum fructosamine vs glycohemoglobin as measures of glycemic control in a large diabetic population. Acta Diabetol (1998) 0.82
Chelation therapy in beta-thalassemia major. I. Intravenous and subcutaneous deferoxamine. J Pediatr (1978) 0.81
Hemoglobin distribution width: a rapid assessment of dense red cells in the steady state and during painful crisis in sickle cell anemia. J Lab Clin Med (1988) 0.81
Atypical haplotypes linked to the beta S gene in Africa are likely to be the product of recombination. Am J Hematol (1988) 0.81
Hemoglobin D Ibadan-beta zero thalassemia: detection by neonatal screening and confirmation by electrospray-ionization mass spectrometry. Am J Hematol (1993) 0.81
Nanosecond absorption study of kinetics associated with carbon monoxide rebinding to hemoglobin S and hemoglobin C following ligand photolysis. Biochem Biophys Res Commun (1994) 0.81
A study of intermediates involved in the folding pathway for recombinant human macrophage colony-stimulating factor (M-CSF): evidence for two distinct folding pathways. Protein Sci (1993) 0.81
Intrinsic fluorescence emission of intact oxy hemoglobins. Biochem Biophys Res Commun (1980) 0.81
Erigeron breviscapus prevents defective endothelium-dependent relaxation in diabetic rat aorta. Life Sci (1999) 0.81
Characterizing abnormal hemoglobin by MS. Anal Chem (1996) 0.81
Detection of hemoglobin S polymerization in intact red cells by P-31 NMR. Biochem Biophys Res Commun (1980) 0.81
Immunohistochemical localization of hepatic nitric oxide synthase in normal and transgenic sickle cell mice: the effect of hypoxia. Blood (1996) 0.81
Protection from lethal malaria in transgenic mice expressing sickle hemoglobin. Blood (1996) 0.81
Open half-volume quadrature transverse electromagnetic coil for high-field magnetic resonance imaging. Magn Reson Med (2005) 0.80
Conformational studies of hemoglobins using intrinsic fluorescence measurements. J Biol Chem (1981) 0.80
In vivo quantitation of water content in muscle tissues by NMR imaging. Magn Reson Imaging (1991) 0.80
Suramin inhibits the toxic effects of presynaptic neurotoxins at the mouse motor nerve terminals. Eur J Pharmacol (1999) 0.80